5 Biggest Biotechnology ETFs in 2026
Source: Investing News Network
2026-06-02 16:10:00 ET
The biotech sector has made significant strides in recent years, and the market's volatility can increase the appeal of biotech ETFs.
Even with a good understanding of the system, no one can predict which treatment, device or therapy will give the biggest return, making biotech exchange-traded funds (ETFs) a more secure option than individual biotech stocks.
An ETF is a relatively safe investment route that can minimize losses while offering exposure to multiple companies instead of focusing on the gains and losses of a single biotech stock.
For further details see:
5 Biggest Biotechnology ETFs in 2026
Revolution Medicines Inc - Ordinary Shares
NASDAQ: RVMD
RVMD Trading
2.0% G/L:
$157.76 Last:
1,106,199 Volume:
$156.275 Open:
RVMD Latest News
June 03, 2026 08:30:00 am
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
RVMD Stock Data
$18,541,302,498
177,467,581
0.42%
132
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
